126 related articles for article (PubMed ID: 15125611)
21. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
[TBL] [Abstract][Full Text] [Related]
22. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
24. Encouraging the outcomes of children with beta-thalassaemia major who underwent fresh cord blood transplantation from an HLA-matched sibling donor.
Wen J; Wang X; Chen L; He Y; Feng X; Li C; Ruan Y; Liu S; Wu X
Hematology; 2022 Dec; 27(1):310-317. PubMed ID: 35220923
[TBL] [Abstract][Full Text] [Related]
25. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
[TBL] [Abstract][Full Text] [Related]
26. Engraftment failure following bone marrow transplantation in children with thalassemia major using busulfan and cyclophosphamide conditioning.
Solh H; Rao K; Martins da Cunha A; Padmos A; Giri N; Spence D; Clink H; Ernst P
Pediatr Hematol Oncol; 1997; 14(1):73-7. PubMed ID: 9021816
[TBL] [Abstract][Full Text] [Related]
27. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
28. Thalassemia Major: Transplantation or Transfusion and Chelation.
Mohamed SY
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):290-298. PubMed ID: 28651066
[TBL] [Abstract][Full Text] [Related]
29. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia.
Jaing TH; Yang CP; Hung IJ; Chen SH; Sun CF; Chow R
Bone Marrow Transplant; 2007 Aug; 40(4):307-11. PubMed ID: 17572710
[TBL] [Abstract][Full Text] [Related]
30. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
[TBL] [Abstract][Full Text] [Related]
31. Co-Transplantation of Haploidentical Stem Cells and a Dose of Unrelated Cord Blood in Pediatric Patients with Thalassemia Major.
Wang X; Zhang X; Yu U; Wang C; Yang C; Li Y; Li C; Wen F; Li C; Liu S
Cell Transplant; 2021; 30():963689721994808. PubMed ID: 33593080
[TBL] [Abstract][Full Text] [Related]
32. Successful unrelated umbilical cord blood transplantation for class 3 β-thalassemia major using a reduced-toxicity regimen.
Soni S; Breslin N; Cheerva A
Pediatr Transplant; 2014 Mar; 18(2):E41-3. PubMed ID: 24330091
[TBL] [Abstract][Full Text] [Related]
33. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Hsu J; Artz A; Mayer SA; Guarner D; Bishop MR; Reich-Slotky R; Smith SM; Greenberg J; Kline J; Ferrante R; Phillips AA; Gergis U; Liu H; Stock W; Cushing M; Shore TB; van Besien K
Biol Blood Marrow Transplant; 2018 Feb; 24(2):359-365. PubMed ID: 29128555
[TBL] [Abstract][Full Text] [Related]
34. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
Sauer M; Bettoni C; Lauten M; Ghosh A; Rehe K; Grigull L; Beilken A; Welte K; Sykora KW
Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
[TBL] [Abstract][Full Text] [Related]
35. Outcomes after Unrelated Umbilical Cord Blood Transplantation for Children with Osteopetrosis.
Chiesa R; Ruggeri A; Paviglianiti A; Zecca M; Gónzalez-Vicent M; Bordon V; Stein J; Lawson S; Dupont S; Lanino E; Abecasis M; Al-Seraihy A; Kenzey C; Bierings M; Locatelli F; Gluckman E; Schulz A; Gennery A; Page K; Kurtzberg J; Rocha V;
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1997-2002. PubMed ID: 27470286
[TBL] [Abstract][Full Text] [Related]
36. [Influence of total nucleated cell dose on the efficacy of cord blood transplantation].
Liu S; Hao WG; Huang YL; Sun X
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):551-6. PubMed ID: 20637155
[TBL] [Abstract][Full Text] [Related]
37. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplantation for beta-thalassaemia major by an HLA-mismatched parent.
Li CF; Zhang YM; Wu XD; He YL; Sun J; Chen SJ; Li CK; Tsang KS
J Paediatr Child Health; 2002 Jun; 38(3):308-10. PubMed ID: 12047703
[TBL] [Abstract][Full Text] [Related]
39. Directed sibling donor cord blood banking for children with beta-thalassemia major in Greece: usage rate and outcome of transplantation for HLA-matched units.
Goussetis E; Petrakou E; Theodosaki M; Kitra V; Peristeri I; Vessalas G; Dimopoulou MN; Spiropoulos A; Papassavas AC; Stavropoulos-Giokas C; Graphakos S
Blood Cells Mol Dis; 2010; 44(2):107-10. PubMed ID: 19931473
[TBL] [Abstract][Full Text] [Related]
40. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
